The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial
ESCAPE
1 other identifier
interventional
1,000
1 country
50
Brief Summary
The purpose of the study is to evaluate the efficacy and safety of Butylphthalide Soft Capsules (En Bi Pu, NBP) in Secondary Prevention of Ischemic Stroke
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4 stroke
Started Aug 2008
Typical duration for phase_4 stroke
50 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 26, 2008
CompletedFirst Posted
Study publicly available on registry
July 29, 2008
CompletedStudy Start
First participant enrolled
August 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedFebruary 24, 2011
February 1, 2011
2.8 years
July 26, 2008
February 23, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Newly onset ischemic stroke
1 year follow up
vascular events including newly onset TIA,intracerebral hemorrhage,myocardic infarction,unstable angina pectoris, occlusion of peripheral artery
1 year follow up
Small vessel disease defined by white matter lesions on MRI
1 year follow up
Secondary Outcomes (1)
All-cause death
1 year follow up
Study Arms (2)
1
EXPERIMENTALButylphthalide Soft Capsules + Aspirin
2
ACTIVE COMPARATORAspirin
Interventions
Butylphthalide Soft Capsules: 2 tablets Bid for 1 year Aspirin: 100mg for 1 year
Eligibility Criteria
You may qualify if:
- Ischemic cerebral infarction or TIA within 90 days.
- Aged above 40 years old.
- Cranial CT or MRI scan exclude intracranial hemorrhagic diseases
- Stable clinical and neurological conditions.
- Informed consent is obtained.
You may not qualify if:
- Intracranial hemorrhage
- Stroke of other unkonwn causes, or other known causes, such as Takayasu arteritis, Moyamoya disease, dissecting aneurysm and hypercoagulable state, carotid endarterectomy, angiogram, or cardiac surgery
- Cardio embolism
- Patients with anticoagulants treament including heparin or warfarin
- Severe co-morbid or unstable medical condition, ie, heart failure, respiratory failure and renal failure, severe liver dysfunction, malignancy with likelihood of death within the next 2 years
- Significant memory or behavioural disorder, ie, Alzheimer disease, etc, daily care needed.
- A Modified Rankin score is more than 4
- Abnormal liver function: ALT or AST level \>1.5 times upper limit of normal; Abnormal renal function: serum creatinine level \>2.0mg/dl or 177umol/l:
- Concurrent participation in another clinical trial
- Uncontrolled hypertension : systolic blood pressure greater than 180mmHg, or diastolic blood pressure greater than 100mmHg
- Haemostatic disorder or thrombocytopenia (i.e., PLT\<100Ă—109/l).
- Currently active peptic ulcer disease
- Pregnant or breast feeding
- Planned for major surgery, carotid endarterectomy, or carotid angioplasty
- Unable to give informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (50)
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
Peking Union Medical College Hosptial
Beijing, Beijing Municipality, 100730, China
China Pla General Hospital
Beijing, Beijing Municipality, 100853, China
Beijing Daxing District Hospital
Beijing, Beijing Municipality, China
Beijing Ji Shui Tan Hospital,the 4Th Medical College of Peking University
Beijing, Beijing Municipality, China
Beijing Shijitan Hospital
Beijing, Beijing Municipality, China
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China
China Rehabilition Research Center
Beijing, Beijing Municipality, China
General Hospital of Navy
Beijing, Beijing Municipality, China
Luhe Hospital of Tongzhou Distict Beijing
Beijing, Beijing Municipality, China
No 263 Hospital of Pla
Beijing, Beijing Municipality, China
No 309 Hospital of Pla
Beijing, Beijing Municipality, China
Peking University Third Hospital
Beijing, Beijing Municipality, China
Pinggu County Hospital Beijing
Beijing, Beijing Municipality, China
Xuanwu Hospital Capital Medical University
Beijing, Beijing Municipality, China
Daping Hospital
Chongqing, Chongqing Municipality, China
Southwest Hospital
Chongqing, Chongqing Municipality, China
Guangzhou First Municipal People'S Hospital
Guangzhou, Guangdong, China
The First Affiliated Hospital,Sun Yat-Sen Unversity
Guangzhou, Guangdong, China
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
The Third Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Yutian County Hospital
Yutian, Hebei, China
Hebei North University
Zhangjiakou, Hebei, China
The First Hospital of Harbin Medical University
Harbin, Helongjiang, China
The Second Hospital of Harbin Medical University
Harbin, Helongjiang, China
Henan Provincial People'S Hospital
Zhengzhou, Henan, China
The Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
Xiangya Hospital of Centre-South University
Changsha, Hunan, China
Inner Mongolia Baotou City Central Hospital
Baotou, Inner Mongolia, China
The Appurtenant Hospital of Chifeng University
Chifeng, Inner Mongolia, China
Jiangsu Province Hospital
Nanjing, Jiangsu, China
Nanjing General Hospital of Nanjing Military Command
Nanjing, Jiangsu, China
The Affiliated Drumtower Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China
The Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
Jilin University
Changchun, Jilin, China
The Third People'S Hospital of Dalian
Dalian, Liaoning, China
The First Affiliated Hospital of China Medical Sciences University
Shenyang, Liaoning, China
Qinghai Provincial People'S Hospital
Xining, Qinghai, China
Qilu Hospital of Shangdong University
Jinan, Shandong, China
The Second Hospitalof Shangdong University
Jinan, Shandong, China
Huashan Hospital Fudan University
Shanghai, Shanghai Municipality, China
Shanghai Changzheng Hospital
Shanghai, Shanghai Municipality, China
West China Center of Medical Sciences
Chengdu, Sichuan, China
The General Hospital Under Tianjin Medical Sciences University
Tianjin, Tianjin Municipality, China
Tianjin Third Central Hospital
Tianjin, Tianjin Municipality, China
First Affiliated Hospital of Xinjiang Medical University
Uramuqi, Xinjiang Uygur Autonomous Region, China
Second Affiliated Hospital Zhejiang University College of Medicine
Hangzhou, Zhejiang, China
The First Affiliated Hospital of College of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 26, 2008
First Posted
July 29, 2008
Study Start
August 1, 2008
Primary Completion
June 1, 2011
Study Completion
August 1, 2011
Last Updated
February 24, 2011
Record last verified: 2011-02